10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2018

Commission file number: 000-53450

REMSLEEP HOLDINGS, INC.

(Name of registrant as specified in its charter)

Nevada	47-5386867
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

637 N. Orange Ave, Suite 609, Orlando, FL 32789

(Address of principal executive offices) (Zip Code)

912-590-2001

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [   ] No [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[   ]	Accelerated filer	[   ]
Non-accelerated filer	[   ]	Smaller reporting company	[X]
Emerging growth company	[   ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [   ] No [X]

As of June 26, 2018, there were 5,875,894 shares of common stock outstanding.

TABLE OF CONTENTS

		Page No.
PART I. - FINANCIAL INFORMATION
Item 1.	Financial Statements.	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Plan of Operations.	10
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	12
Item 4	Controls and Procedures.	12
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings.	13
Item 1A.	Risk Factors.	13
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	13
Item 3.	Defaults Upon Senior Securities.	13
Item 4.	Mine Safety Disclosures	13
Item 5.	Other Information.	13
Item 6.	Exhibits.	14
Signatures		14

2

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

REMSLEEP HOLDINGS, INC.

Condensed Balance Sheets as of March 31, 2018 (Unaudited) and December 31, 2017 (Audited)	4
Condensed Statements of Operations for the Three Months ended March 31, 2018 and 2017 (Unaudited)	5
Condensed Statements of Cash Flows for the Three Months ended March 31, 2018 and 2017 (Unaudited)	6
Condensed Notes to Financial Statements (Unaudited)	7

3

REMSLEEP HOLDINGS, INC. CONDENSED BALANCE SHEETS
		March 31, 2018		December 31, 2017
ASSETS		(Unaudited)
Current assets:
Cash	$	52,261	$	2,014
Prepaid stock for services		57,761		173,282
Total current assets		110,022		175,296
Property and equipment, net		7,970		8,486
Total Assets	$	117,992	$	183,782
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
Accounts payable	$	242,898	$	239,878
Accrued compensation		1,150		2,850
Accrued interest		12,957		12,341
Accrued stock to be issued		-		194,068
Due to shareholder		182,191		182,191
Loan payable		50,000		50,000
Total Liabilities		489,196		681,328
STOCKHOLDERS' EQUITY (DEFICIT)
Series A preferred stock, no par value, 5,000,000 shares authorized, 3,500,000 and 3,500,000 issued and outstanding, respectively		105,000		105,000
Series B preferred stock, no par value, 5,000,000 shares authorized, no shares issued		-		-
Series C preferred stock, no par value, 5,000,000 shares authorized, no shares issued		-		-
Common stock, $.001 par value, 1,000,000,000 shares authorized, 3,937,894 and 3,610,751 shares issued and outstanding, respectively
		3,938		3,611
Common stock to be issued		269,188		58,225
Additional paid in capital		502,111		424,938
Accumulated Deficit		(1,251,441)		(1,089,320)
TOTAL STOCKHOLDERS' DEFICIT		(371,204)		(497,546)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	117,992	$	183,782

The accompanying notes are an integral part of these unaudited condensed financial statements.

4

REMSLEEP HOLDINGS, INC. CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
		For the Three Months Ended March 31,
		2018		2017
				(Restated)
OperatingExpenses:
Professional fees	$	16,150	$	12,600
Consulting		117,521		146,979
Officer compensation		6,000		6,000
General and administrative		4,939		7,024
Total operating expenses		144,610		172,603
Loss from operations		(144,610)		(172,603)
Other expenses:
Interest expense		(616)		-
Change in fair value		(16,895)		-
Total other expense		(17,511)		-
Loss before income taxes		(162,121)		(172,603)
Provision for income taxes		-		-
Net Loss	$	(162,121)	$	(172,603)
Basic and fully diluted net loss per share	$	(0.04)	$	(0.05)
Weighted average common shares outstanding, basic and diluted		3,678,577		3,285,584

The accompanying notes are an integral part of these unaudited condensed financial statements.

5

REMSLEEP HOLDINGS, INC. CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
		For the Three Months Ended March 31,
		2018			2017
Cash Flows from Operating Activities:					(Restated)
Net loss	$	(162,121)		$		(172,603)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation expense		516				2,810
Stock issued for services		115,521				146,979
Change in fair value		16,895				-
Changes in Operating Assets and Liabilities
Accounts Payable		3,020				1,380
Accrued officer compensation		(1,700)				2,000
Accrued interest		616				-
Net cash used in operating activities		(27,253)				(19,434)
Cash Flows from Investing Activities:		-				-
Cash Flows from Financing Activities:
Proceeds from shareholder advances		-				19,434
Proceeds from sale of common stock		77,500				-
Net cash provided by financing activities		77,500				19,434
Net increase in cash		50,247				-
Cash at beginning of the period		2,014				-
Cash at end of the period	$	52,261		$		-
Supplemental cash flow information:
Interest paid in cash	$	-	$		-
Taxes paid	$	-	$		-
Supplemental non-cash disclosure:
Stock issued for services	$	115,521	$		146,979

The accompanying notes are an integral part of these unaudited condensed financial statements.

6

REMSLEEP HOLDINGS, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

March 31, 2018

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business Activity

REMSleep Holdings, Inc., (the “Company”) was incorporated in the State of Nevada on June 6, 2007. Following its acquisition of Handcamp on June 4, 2010, a gold property located in the Province of Newfoundland and Labrador, Canada (“Handcamp”), the Company changed its business model to that of a mineral acquisition, exploration and development company focused primarily on gold properties. On August 26, 2010, the Company’s name was changed from Bella Viaggio, Inc. to Kat Gold Holdings Corp. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea. On May 30, 2015 REMSleep LLC was formerly merged into REMSleep Holdings, Inc.

Basis of Presentation

These unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in the Company’s 10-K for its fiscal year ended December 31, 2017. In the opinion of the Company, all adjustments, including normal recurring adjustments necessary to present fairly the financial position of the Company, as of March 31, 2018 and the results of its operations and cash flows for the three-month periods then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

Reclassifications

Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the restated financial statements for the three months ended March 31, 2018.

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements will cause a material impact on its financial condition or the results of its operations.

NOTE 2 - GOING CONCERN

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has an accumulated deficit of $1,251,441 at March 31, 2018, had a net loss of $162,121 and net cash used in operating activities of $27,253 for the three months ended March 31, 2018. The Company’s ability to raise additional capital through the future issuances of common stock and/or debt financing is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. These conditions and the ability to successfully resolve these factors over the next twelve months raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

7

REMSLEEP HOLDINGS, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

March 31, 2018

NOTE 3 - PROPERTY & EQUIPMENT

Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets as follows between three and five years.

Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.

Assets stated at cost, less accumulated depreciation consisted of the following:

		March 31, 2018		December 31, 2017
Equipment	$	14,904	$	14,904
Less: accumulated depreciation		(6,934)		(6,418)
Fixed assets, net	$	7,970	$	8,486

Depreciation expense

Depreciation expense for the three months ended March 31, 2018 and 2017 was $516 and $2,810, respectively.

NOTE 4 – NOTES PAYABLE

On October 24, 2017, the Company was notified that a petition had been filed in the Iowa District Court for Polk County by a Mr. John M. Wesson for failure to repay a loan. Mr. Wesson had loaned the Company $30,000 and $20,000 on October 24, 2012 and June 12, 2013, respectively. The loans were to accrue interest at 5%. While the Company was under previous management the loans were removed from the books in Q1 of 2015. On April 26, 2018, the Company agreed to repay the loan in full including accrued interest and $5,000 for legal fees. The $50,000 plus $7,341 was booked to retained earnings in 2016 as a correction of an error. As of March 31, 2018, there is $12,957 of interest accrued on the loan.

NOTE 5 - COMMON STOCK

On November 16, 2017, the Company issued, as compensation for services provided, 1,087,261 common shares with a fair value of $0.2125 per share for total non-cash expense of $231,043. The expense is being recognized over the six-month term of the contract. As of December 31, 2017, $57,761 has been debited to consulting expense. In addition, as of December 31, 2017, the shares have not yet been issued; as a result, $36,975 has been credited to common stock to be issued and the remaining $194,068 to accruals. As of March 31, 2018, the shares were re-valued at $0.231 for a change in value of $16,895. In addition, $115,521 was amortized to stock for services expense and the accrual for stock to be issued was reclassed to common stock to be issued in equity.

During the three months ended March 31, 2018, the Company sold 327,143 shares of common stock for total cash proceeds of $77,500.

NOTE 6 - PREFERRED STOCK

The Company is currently authorized to issue 5,000,000 Class A preferred shares, $0.001 per value with 1:25 voting rights.

On February 25, 2016, the Company issued 2,000,000 Class A preferred shares. On April 26, 2016 the Company issued 1,500,000 Class A preferred shares. The fair value of the shares was based on the price quoted on the OTC pink sheets on the grant date for the common shares as the preferred shares have a preference of a 1 to 1 conversion to common stock. The Company recognized compensation expense to its officers. As of March 31, 2018, there are 3,500,000 Class A Preferred shares outstanding.

8

REMSLEEP HOLDINGS, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

March 31, 2018

NOTE 7 - RELATED PARTY TRANSACTIONS

The Company has received support from parties related through common ownership and directorship. All of the expenses herein have been borne by these individuals on behalf of the Company and are treated as shareholder loans. These loans are unsecured, non-interest bearing and due on demand. As of March 31, 2018, and December 31, 2017, the balance due on these loans is $182,191 and $182,191, respectively.

NOTE 8 – RESTATEMENT

The March 31, 2017 financial statements are being restated to revise the accounting for retroactive adjustments identified during the year ended December 31, 2017 audit.

The following table summarizes changes made to the three months ended March 31, 2017 Statement of Operations.

	For the three months ended March 31, 2017
		As Reported		Adjustment		As Restated
Operating expenses	$	58,212	$	114,391	$	172,603
Net Loss	$	(58,212)	$	(114,391)	$	(172,603)

NOTE 9 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued, June 26, 2018 and has determined that it does not have any material subsequent events to disclose in these financial statements other then the following.

Subsequent to March 31, 2018, the Company granted 1,938,000 shares of common stock for services.

On April 27, 2018, the Company made a $10,000 payment as required by the Forbearance Agreement with regards to the Note Payable (Note 4).

9

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS.

Forward-looking Statements

There are “forward-looking statements” contained in this quarterly report. All statements that express expectations, estimates, forecasts or projections are forward-looking statements. In addition, other written or oral statements which constitute forward-looking statements may be made by us or on our behalf. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “project,” “forecast,” “may,” “should,” variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in or suggested by such forward-looking statements. We undertake no obligation to update or revise any of the forward-looking statements after the date of this quarterly report to conform forward-looking statements to actual results. Important factors on which such statements are based are assumptions concerning uncertainties, including but not limited to, uncertainties associated with the following:

Inadequate capital and barriers to raising the additional capital or to obtaining the financing needed to implement our business plans; 

Our failure to earn revenues or profits; 

Inadequate capital to continue business; 

Volatility or decline of our stock price; 

Potential fluctuation in quarterly results; 

Rapid and significant changes in markets; 

Litigation with or legal claims and allegations by outside parties; and 

Insufficient revenues to cover operating costs. 

The following discussion should be read in conjunction with the financial statements and the notes thereto which are included in this quarterly report. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ substantially from those anticipated in any forward-looking statements included in this discussion as a result of various factors.

Overview

We were incorporated in the State of Nevada on June 6, 2007. On August 26, 2010, we changed our name from Bella Viaggio, Inc. to Kat Gold Holdings Corp. Effective January 1, 2015, we entered into an exchange agreement to purchase 100% of the outstanding interests of RemSleep LLC in exchange for 50,000,000 common shares of RemSleep Holdings, Inc.’s stock (the “Exchange Agreement”). As a result of the exchange, RemSleep LLC became our wholly-owned subsidiary and constitutes our business and operations and we changed our name to REMSleep Holdings, Inc. to reflect our new business model of developing and distributing sleep apnea products.

Our officers have 35 years of sleep-industry experience, including working at sleep industry companies. Our officers invented our DeltaWave CPAP (continuous positive airway pressure) interface (the “DeltaWave”). We have developed the DeltaWave as an innovative new device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillows type interface designed to result in better comfort and, therefore, better compliance. The Delta Wave is specifically designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. A survey that appeared in DME Business found that 89% of patients stated that mask-interface comfort was their primary concern. The primary issue that we have addressed with the DeltaWave is the “work of breathing” component. We believe that our DeltaWave is designed to effectively address the stubborn issues that continue to affect a patient’s ability to comply with treatment, as follows:

Does not disrupt normal breathing mechanics; 

Is not claustrophobic; 

Causes zero work of breathing (WOB); 

Minimizes or eliminates drying of the sinuses; 

Uses less driving pressure; and 

Allows users to feel safe and secure while sleeping. 

We plan to conduct clinical trials to test product effectiveness.

Our goal is to develop sleep products that achieve optimum compliance and comfort for CPAP patients.

10

On June 28, 2016, we applied for a patent for a new, innovative sleep apnea product that serves as an interface for the delivery of CPAP therapy and other respiratory needs.

Our website is located at: http://www.remsleeptech.com.

Results of Operations

The three months ended March 31, 2018 compared to the three months ended March 31, 2017

Professional fees were $16,150 and $12,600 for the three months ended March 31, 2018 and 2017, respectively, an increase of $3,550, or 28.2%. Professional fees consist mostly of accounting, audit and legal fees.

Consulting expense was $117,521 and $146,979 for the three months ended March 31, 2018 and 2017, respectively, a decrease of $29,458, or 20.0%. In the current period we recognized $115,521 of non-cash stock compensation expense, In the previous period we issued 37,500 shares of common stock to consultants for total non-cash expense of $146,979.

Officer compensation was $6,000 and $6,000 for the three months ended March 31, 2018 and 2017, respectively.

General and administrative expense was $4,939 and $7,024 for the three months ended March 31, 2018 and 2017, respectively, a, decrease of $2,085, or 29.7%.

Net Loss

For the three months ended March 31, 2018, we had a net loss of $162,121 as compared to a net loss of $172,603 for the three months ended March 31, 2017. Our net loss was lower in the current period primarily due to the expense associated with issuing stock for services.

Going Concern

As of March 31, 2018, there is substantial doubt regarding our ability to continue as a going concern as we have not generated sufficient cash flow to fund our proposed business.

We have suffered recurring losses from operations since our inception. In addition, we have yet to generate an internal cash flow from our business operations or successfully raised the financing required to develop our proposed business. As a result of these and other factors, our independent auditor has expressed substantial doubt about our ability to continue as a going concern. Our future success and viability, therefore, are dependent upon our ability to generate capital financing. The failure to generate sufficient revenues or raise additional capital may have a material and adverse effect upon us and our shareholders.

Management’s plans with regard to these matters encompass the following actions: (i) obtaining funding from new investors to alleviate our working capital deficiency, and (ii) implementing a plan to generate sales. Our continued existence is dependent upon our ability to resolve our liquidity problems and increase profitability in our current business operations. However, the outcome of management’s plans cannot be ascertained with any degree of certainty. Our financial statements do not include any adjustments that might result from the outcome of these risks and uncertainties.

Liquidity and Capital Resources

Cash flow from operations.

Net cash flow used in operating activities for the three months ended March 31, 2018 was $27,253 as compared to $19,434 of net cash flows used in operating activities for the same period ended 2017.

Cash Flows from Financing

The net cash flows from financing activities for the three months ended March 31, 2018 were $77,500 from the sale of common stock as compared to $19,434 from related party loans for the same period ended 2017.

11

Off Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes. Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

We are subject to various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities. The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled. Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

Recent Accounting Pronouncements

We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe that any future adoption of such pronouncements will have a material impact on our financial condition or the results of our operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not Applicable

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Each of our principal executive and principal financial officer has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a - 15(e) and 15d - 15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of the end of the period covered by this quarterly report. Based on their evaluation, each such person concluded that our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting as of March 31, 2018. Our management intends, during the 2018 fiscal year, to design and implement processes and procedures that will provide reasonable assurance regarding the reliability of our financial reporting and preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Changes in Internal Control over Financial Reporting.

Our management has evaluated whether any change in our internal control over financial reporting occurred during the last fiscal quarter. Based on that evaluation, management concluded that there has been no change in our internal control over financial reporting during the relevant period that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

12

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended March 31, 2018, the Company sold 327,143 shares of common stock for total cash proceeds of $77,500.

During April 2018, the Company granted 1,938,000 shares of common stock for services.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

13

ITEM 6. EXHIBITS

(a) Documents furnished as exhibits hereto:

Exhibit No.	Description
31.1	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	REMSLEEP HOLDINGS CORP.
Date: June 28, 2018	By: /s/Tom Wood
	Tom Wood
	Principal Executive Officer/Principal Financial Officer/Director

14

EX-31.1

CERTIFICATION

I, Tom Wood, certify that:

1. I have reviewed this Form 10-Q for the quarter ended March 31, 2018 of REMSleep Holdings, Inc.:

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

June 28, 2018

/s/ Tom Wood

Tom Wood

Chief Executive Officer/Chief Financial Officer/Chief Accounting Officer

EX-31.2

CERTIFICATION

I, Tom Wood, certify that:

1. I have reviewed this Form 10-Q for the quarter ended March 31, 2018 of REMSleep Holdings, Inc.:

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

June 28, 2018

/s/ Tom Wood

Tom Wood

Chief Executive Officer/Chief Financial Officer/Chief Accounting Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Tom Wood, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of REMSleep Holdings, Inc. on Form 10-Q for the quarterly period ended March 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of REMSleep Holdings, Inc.

By: /s/Tom Wood

Tom Wood

Chief Executive Officer/Chief Financial Officer/Chief Accounting Officer

June 28, 2018

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2018	Jun. 26, 2018
Details
Registrant Name	RemSleep Holdings Inc.
Registrant CIK	0001412126
SEC Form	10-Q
Period End date	Mar. 31, 2018
Fiscal Year End	--12-31
Trading Symbol	RMSL
Tax Identification Number (TIN)	475386867
Number of common stock shares outstanding		5,875,894
Filer Category	Smaller Reporting Company
Current with reporting	Yes
Voluntary filer	No
Well-known Seasoned Issuer	No
Amendment Flag	false
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Entity Incorporation, State Country Name	Nevada
Entity Address, Address Line One	637 N. Orange Ave, Suite 609
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32789
City Area Code	912
Local Phone Number	590-2001

XML

Condensed Balance Sheets (March 31, 2018 Unaudited) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash	$ 52,261	$ 2,014
Prepaid stock for services	57,761	173,282
Total current assets	110,022	175,296
Property and equipment, net	7,970	8,486
Total Assets	117,992	183,782
Current Liabilities:
Accounts payable	242,898	239,878
Accrued compensation	1,150	2,850
Accrued interest	12,957	12,341
Accrued stock to be issued	0	194,068
Due to shareholder	182,191	182,191
Loan payable	50,000	50,000
Total Liabilities	489,196	681,328
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock, Value, Issued	3,938	3,611
Common stock to be issued	269,188	58,225
Additional paid in capital	502,111	424,938
Accumulated Deficit	(1,251,441)	(1,089,320)
TOTAL STOCKHOLDERS' DEFICIT	(371,204)	(497,546)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	117,992	183,782
Series A Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred Stock, Value, Issued	105,000	105,000
Series B Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred Stock, Value, Issued	0	0
Series C Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred Stock, Value, Issued	$ 0	$ 0

XML

Condensed Balance Sheets (March 31, 2018 Unaudited) - Parenthetical - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	3,937,894	3,610,751
Common Stock, Shares, Outstanding	3,937,894	3,610,751
Series A Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0	$ 0
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	3,500,000	3,500,000
Preferred Stock, Shares Outstanding	3,500,000	3,500,000
Series B Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0	$ 0
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Series C Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0	$ 0
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0

XML

Condensed Statements of Operations (Unaudited, 2017 restated) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating Expenses:
Professional fees	$ 16,150	$ 12,600
Consulting	117,521	146,979
Officer compensation	6,000	6,000
General and administrative	4,939	7,024
Total operating expenses	144,610	172,603
Loss from operations	(144,610)	(172,603)
Other expenses:
Interest expense	(616)	0
Change in fair value	(16,895)	0
Total other expense	(17,511)	0
Loss before income taxes	(162,121)	(172,603)
Provision for income taxes	0	0
Net Loss	$ (162,121)	$ (172,603)
Basic and fully diluted net loss per share	$ (0.04)	$ (0.05)
Weighted average common shares outstanding, basic and diluted	3,678,577	3,285,584

XML

Condensed Statements of Cash Flows (Unaudited, 2017 restated) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash Flows from Operating Activities:
Net loss	$ (162,121)	$ (172,603)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation expense	516	2,810
Stock issued for services	115,521	146,979
Change in fair value	16,895	0
Changes in Operating Assets and Liabilities
Accounts Payable	3,020	1,380
Accrued officer compensation	(1,700)	2,000
Accrued interest	616	0
Net cash used in operating activities	(27,253)	(19,434)
Cash Flows from Investing Activities:	0	0
Cash Flows from Financing Activities:
Proceeds from shareholder advances	0	19,434
Proceeds from sale of common stock	77,500	0
Net cash provided by financing activities	77,500	19,434
Net increase in cash	50,247	0
Cash and Cash Equivalents, at Carrying Value, Beginning Balance	2,014	0
Cash and Cash Equivalents, at Carrying Value, Ending Balance	52,261	0
Supplemental cash flow information:
Interest paid in cash	0	0
Taxes paid	0	0
Supplemental non-cash disclosure:
Stock issued for services	$ 115,521	$ 146,979

XML

Note 1 - Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2018

Notes

Note 1 - Summary of Significant Accounting Policies

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business Activity

REMSleep Holdings, Inc., (the “Company”) was incorporated in the State of Nevada on June 6, 2007. Following its acquisition of Handcamp on June 4, 2010, a gold property located in the Province of Newfoundland and Labrador, Canada (“Handcamp”), the Company changed its business model to that of a mineral acquisition, exploration and development company focused primarily on gold properties. On August 26, 2010, the Company’s name was changed from Bella Viaggio, Inc. to Kat Gold Holdings Corp. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea. On May 30, 2015 REMSleep LLC was formerly merged into REMSleep Holdings, Inc.

Basis of Presentation

These unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in the Company’s 10-K for its fiscal year ended December 31, 2017. In the opinion of the Company, all adjustments, including normal recurring adjustments necessary to present fairly the financial position of the Company, as of March 31, 2018 and the results of its operations and cash flows for the three-month periods then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

Reclassifications

Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the restated financial statements for the three months ended March 31, 2018.

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements will cause a material impact on its financial condition or the results of its operations.

XML

Note 2 - Going Concern

3 Months Ended

Mar. 31, 2018

Notes

Note 2 - Going Concern

NOTE 2 - GOING CONCERN

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has an accumulated deficit of $1,251,441 at March 31, 2018, had a net loss of $162,121 and net cash used in operating activities of $27,253 for the three months ended March 31, 2018. The Company’s ability to raise additional capital through the future issuances of common stock and/or debt financing is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. These conditions and the ability to successfully resolve these factors over the next twelve months raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

XML

Note 3 - Property & Equipment

3 Months Ended

Mar. 31, 2018

Notes

Note 3 - Property & Equipment

NOTE 3 - PROPERTY & EQUIPMENT

Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets as follows between three and five years.

Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.

Assets stated at cost, less accumulated depreciation consisted of the following:

		March 31, 2018		December 31, 2017
Equipment	$	14,904	$	14,904
Less: accumulated depreciation		(6,934)		(6,418)
Fixed assets, net	$	7,970	$	8,486

Depreciation expense

Depreciation expense for the three months ended March 31, 2018 and 2017 was $516 and $2,810, respectively.

XML

NOTE 4 - Notes Payable

3 Months Ended

Mar. 31, 2018

Notes

NOTE 4 - Notes Payable

NOTE 4 – NOTES PAYABLE

On October 24, 2017, the Company was notified that a petition had been filed in the Iowa District Court for Polk County by a Mr. John M. Wesson for failure to repay a loan. Mr. Wesson had loaned the Company $30,000 and $20,000 on October 24, 2012 and June 12, 2013, respectively. The loans were to accrue interest at 5%. While the Company was under previous management the loans were removed from the books in Q1 of 2015. On April 26, 2018, the Company agreed to repay the loan in full including accrued interest and $5,000 for legal fees. The $50,000 plus $7,341 was booked to retained earnings in 2016 as a correction of an error. As of March 31, 2018, there is $12,957 of interest accrued on the loan.

XML

Note 5 - Common Stock

3 Months Ended

Mar. 31, 2018

Notes

Note 5 - Common Stock

NOTE 5 - COMMON STOCK

On November 16, 2017, the Company issued, as compensation for services provided, 1,087,261 common shares with a fair value of $0.2125 per share for total non-cash expense of $231,043. The expense is being recognized over the six-month term of the contract. As of December 31, 2017, $57,761 has been debited to consulting expense. In addition, as of December 31, 2017, the shares have not yet been issued; as a result, $36,975 has been credited to common stock to be issued and the remaining $194,068 to accruals. As of March 31, 2018, the shares were re-valued at $0.231 for a change in value of $16,895. In addition, $115,521 was amortized to stock for services expense and the accrual for stock to be issued was reclassed to common stock to be issued in equity.

During the three months ended March 31, 2018, the Company sold 327,143 shares of common stock for total cash proceeds of $77,500.

XML

Note 6 - Preferred Stock

3 Months Ended

Mar. 31, 2018

Notes

Note 6 - Preferred Stock

NOTE 6 - PREFERRED STOCK

The Company is currently authorized to issue 5,000,000 Class A preferred shares, $0.001 per value with 1:25 voting rights.

On February 25, 2016, the Company issued 2,000,000 Class A preferred shares. On April 26, 2016 the Company issued 1,500,000 Class A preferred shares. The fair value of the shares was based on the price quoted on the OTC pink sheets on the grant date for the common shares as the preferred shares have a preference of a 1 to 1 conversion to common stock. The Company recognized compensation expense to its officers. As of March 31, 2018, there are 3,500,000 Class A Preferred shares outstanding.

XML

Note 7 - Related Party Transactions

3 Months Ended

Mar. 31, 2018

Notes

Note 7 - Related Party Transactions

NOTE 7 - RELATED PARTY TRANSACTIONS

The Company has received support from parties related through common ownership and directorship. All of the expenses herein have been borne by these individuals on behalf of the Company and are treated as shareholder loans. These loans are unsecured, non-interest bearing and due on demand. As of March 31, 2018, and December 31, 2017, the balance due on these loans is $182,191 and $182,191, respectively.

XML

Note 8 - Restatement

3 Months Ended

Mar. 31, 2018

Notes

Note 8 - Restatement

NOTE 8 – RESTATEMENT

The March 31, 2017 financial statements are being restated to revise the accounting for retroactive adjustments identified during the year ended December 31, 2017 audit.

The following table summarizes changes made to the three months ended March 31, 2017 Statement of Operations.

	For the three months ended March 31, 2017
		As Reported		Adjustment		As Restated
Operating expenses	$	58,212	$	114,391	$	172,603
Net Loss	$	(58,212)	$	(114,391)	$	(172,603)

XML

Note 9 - Subsequent Events

3 Months Ended

Mar. 31, 2018

Notes

Note 9 - Subsequent Events

NOTE 9 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued, June 26, 2018 and has determined that it does not have any material subsequent events to disclose in these financial statements other then the following.

Subsequent to March 31, 2018, the Company granted 1,938,000 shares of common stock for services.

On April 27, 2018, the Company made a $10,000 payment as required by the Forbearance Agreement with regards to the Note Payable (Note 4).

XML

Note 1 - Summary of Significant Accounting Policies: Business Activity (Policies)

3 Months Ended

Mar. 31, 2018

Policies

Business Activity

Business Activity

REMSleep Holdings, Inc., (the “Company”) was incorporated in the State of Nevada on June 6, 2007. Following its acquisition of Handcamp on June 4, 2010, a gold property located in the Province of Newfoundland and Labrador, Canada (“Handcamp”), the Company changed its business model to that of a mineral acquisition, exploration and development company focused primarily on gold properties. On August 26, 2010, the Company’s name was changed from Bella Viaggio, Inc. to Kat Gold Holdings Corp. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea. On May 30, 2015 REMSleep LLC was formerly merged into REMSleep Holdings, Inc.

XML

Note 1 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2018

Policies

Basis of Presentation

Basis of Presentation

These unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in the Company’s 10-K for its fiscal year ended December 31, 2017. In the opinion of the Company, all adjustments, including normal recurring adjustments necessary to present fairly the financial position of the Company, as of March 31, 2018 and the results of its operations and cash flows for the three-month periods then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year.

XML

Note 1 - Summary of Significant Accounting Policies: Use of Estimates (Policies)

3 Months Ended

Mar. 31, 2018

Policies

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

XML

Note 1 - Summary of Significant Accounting Policies: Reclassifications (Policies)

3 Months Ended

Mar. 31, 2018

Policies

Reclassifications

Reclassifications

Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the restated financial statements for the three months ended March 31, 2018.

XML

Note 1 - Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies)

3 Months Ended

Mar. 31, 2018

Policies

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements will cause a material impact on its financial condition or the results of its operations.

XML

Note 3 - Property & Equipment: Property, Plant and Equipment (Tables)

3 Months Ended

Mar. 31, 2018

Tables/Schedules

Property, Plant and Equipment

		March 31, 2018		December 31, 2017
Equipment	$	14,904	$	14,904
Less: accumulated depreciation		(6,934)		(6,418)
Fixed assets, net	$	7,970	$	8,486

XML

Note 8 - Restatement: Changes to Statement of Operations (Tables)

3 Months Ended

Mar. 31, 2018

Tables/Schedules

Changes to Statement of Operations

	For the three months ended March 31, 2017
		As Reported		Adjustment		As Restated
Operating expenses	$	58,212	$	114,391	$	172,603
Net Loss	$	(58,212)	$	(114,391)	$	(172,603)

XML

Note 1 - Summary of Significant Accounting Policies: Business Activity (Details)	3 Months Ended
	Mar. 31, 2018
Entity Incorporation, State Country Name	Nevada
Entity Incorporation, Date of Incorporation	Jun. 06, 2007
Former Name Change 1
Entity Information, Date to Change Former Legal or Registered Name	Aug. 26, 2010
Entity Information, Former Legal or Registered Name	Bella Viaggio, Inc.
Former Name Change 2
Entity Information, Date to Change Former Legal or Registered Name	Jan. 05, 2015
Entity Information, Former Legal or Registered Name	Kat Gold Holdings Corp.
Former Name Change 3
Entity Information, Date to Change Former Legal or Registered Name	May 30, 2015
Entity Information, Former Legal or Registered Name	REMSleep Holdings, Inc.

XML

Note 2 - Going Concern (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Details
Accumulated Deficit	$ (1,251,441)		$ (1,089,320)
Net loss	(162,121)	$ (172,603)
Net cash used in operating activities	$ (27,253)	$ (19,434)

XML

Note 3 - Property & Equipment: Property, Plant and Equipment (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Details
Equipment	$ 14,904	$ 14,904
Less: accumulated depreciation	(6,934)	(6,418)
Fixed assets, net	$ 7,970	$ 8,486

XML

Note 3 - Property & Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Details
Depreciation expense	$ 516	$ 2,810

XML

Note 5 - Common Stock (Details)	Nov. 16, 2017 shares
Details
Shares, Issued	1,087,261

XML

Note 6 - Preferred Stock (Details) - shares	Mar. 31, 2018	Dec. 31, 2017	Nov. 16, 2017	Apr. 26, 2016	Feb. 25, 2016
Shares, Issued			1,087,261
Series A Preferred Stock
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Shares, Issued				1,500,000	2,000,000
Preferred Stock, Shares Outstanding	3,500,000	3,500,000

XML

Note 7 - Related Party Transactions (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Details
Debt Instrument, Collateral	unsecured
Debt Instrument, Interest Rate Terms	non-interest bearing
Debt Instrument, Payment Terms	due on demand
Loans outstanding	$ 182,191	$ 182,191

XML

Note 8 - Restatement: Changes to Statement of Operations (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating expenses	$ 144,610	$ 172,603
Net Loss	$ (162,121)	(172,603)
As Reported
Operating expenses		58,212
Net Loss		(58,212)
Scenario, Adjustment
Operating expenses		114,391
Net Loss		$ (114,391)

XML

Note 9 - Subsequent Events (Details)	3 Months Ended
	Mar. 31, 2018
Event 1
Subsequent Event, Description	Company granted 1,938,000 shares of common stock for services
Event 2
Subsequent Event, Description	Company made a $10,000 payment as required by the Forbearance Agreement with regards to the Note Payable	[1]
Subsequent Event, Date	Apr. 27, 2018

[1] Note 4